Free Trial
NYSE:HCA

HCA Healthcare (HCA) Stock Price, News & Analysis

HCA Healthcare logo
$327.22 +1.75 (+0.54%)
(As of 11/29/2024 ET)

About HCA Healthcare Stock (NYSE:HCA)

Key Stats

Today's Range
$323.99
$327.85
50-Day Range
$324.92
$415.67
52-Week Range
$246.60
$417.14
Volume
626,795 shs
Average Volume
1.54 million shs
Market Capitalization
$82.88 billion
P/E Ratio
14.69
Dividend Yield
0.81%
Price Target
$380.29
Consensus Rating
Moderate Buy

Company Overview

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

HCA Healthcare Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
98th Percentile Overall Score

HCA MarketRank™: 

HCA Healthcare scored higher than 98% of companies evaluated by MarketBeat, and ranked 37th out of 964 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    HCA Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.74, and is based on 11 buy ratings, 5 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    HCA Healthcare has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about HCA Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for HCA Healthcare are expected to grow by 13.11% in the coming year, from $21.97 to $24.85 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of HCA Healthcare is 14.69, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 112.79.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of HCA Healthcare is 14.69, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 76.98.

  • Price to Earnings Growth Ratio

    HCA Healthcare has a PEG Ratio of 1.25. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    HCA Healthcare has a P/B Ratio of 105.55. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about HCA Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    1.63% of the float of HCA Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    HCA Healthcare has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in HCA Healthcare has recently increased by 14.23%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    HCA Healthcare has a dividend yield of 0.81%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    HCA Healthcare does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of HCA Healthcare is 11.85%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, HCA Healthcare will have a dividend payout ratio of 10.62% next year. This indicates that HCA Healthcare will be able to sustain or increase its dividend.

  • Read more about HCA Healthcare's dividend.
  • Percentage of Shares Shorted

    1.63% of the float of HCA Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    HCA Healthcare has a short interest ratio ("days to cover") of 2.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in HCA Healthcare has recently increased by 14.23%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    HCA Healthcare has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 29 news articles for HCA Healthcare this week, compared to 17 articles on an average week.
  • Search Interest

    Only 17 people have searched for HCA on MarketBeat in the last 30 days. This is a decrease of -37% compared to the previous 30 days.
  • MarketBeat Follows

    22 people have added HCA Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 120% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, HCA Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,608,990.00 in company stock.

  • Percentage Held by Insiders

    Only 1.60% of the stock of HCA Healthcare is held by insiders.

  • Percentage Held by Institutions

    62.73% of the stock of HCA Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about HCA Healthcare's insider trading history.
Receive HCA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HCA Healthcare and its competitors with MarketBeat's FREE daily newsletter.

HCA Stock News Headlines

HCA Healthcare: Temporary Setbacks, Long-Term Strength
HCA Healthcare: Temporary Setbacks, Long-Term Strength
HCA Healthcare is one of the nations biggest hospital companies. Despite recent hurricane impacts tis company remains well positioned long term.
Could This Tiny Device Help You Make an Extra $30k a Year?
I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.
Wells Fargo Downgrades HCA Healthcare (HCA)
HCA Healthcare (NYSE:HCA) Cut to "Market Perform" at Raymond James
See More Headlines

HCA Stock Analysis - Frequently Asked Questions

HCA Healthcare's stock was trading at $270.68 at the beginning of the year. Since then, HCA stock has increased by 20.9% and is now trading at $327.22.
View the best growth stocks for 2024 here
.

HCA Healthcare, Inc. (NYSE:HCA) posted its quarterly earnings data on Tuesday, July, 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.97 by $0.53. HCA Healthcare's revenue for the quarter was up 10.3% compared to the same quarter last year.
Read the conference call transcript
.

HCA Healthcare's board approved a stock buyback program on Tuesday, January 30th 2024, which authorizes the company to buy back $6,000,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 7.4% of its shares through open market purchases. Shares buyback programs are often a sign that the company's management believes its stock is undervalued.

HCA Healthcare subsidiaries include Valify, Galen College of Nursing, Mission Health, Highlands Regional Medical Center, Weatherford Regional Medical Center, Memorial University Medical Center, Mobile Heartbeat, and others.

HCA Healthcare's top institutional shareholders include Sanders Capital LLC (4.56%), State Street Corp (3.28%), Wellington Management Group LLP (2.78%) and Geode Capital Management LLC (1.51%). Insiders that own company stock include Thomas F Frist Jr, Charles J Hall, Patricia F Elcan, Bill B Rutherford, Phillip G Billington, Christopher F Wyatt, A Bruce Moore Jr, Michael S Cuffe, P Martin Paslick, Kathryn A Torres, Timothy M Mcmanus, Jon M Foster, Kathleen M Whalen, Sammie S Mosier, Jennifer Berres, Erol R Akdamar, Jeffrey E Cohen, Andrea B Smith, Chad J Wasserman, Michael R Mcalevey, Deborah M Reiner and Joseph A Sowell III.
View institutional ownership trends
.

Shares of HCA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that HCA Healthcare investors own include Chevron (CVX), Bristol-Myers Squibb (BMY), Comcast (CMCSA), McKesson (MCK), Charles Schwab (SCHW), Edwards Lifesciences (EW) and Yum! Brands (YUM).

Company Calendar

Last Earnings
7/23/2024
Ex-Dividend for 9/30 Dividend
9/16/2024
Dividend Payable
9/30/2024
Today
12/01/2024
Ex-Dividend for 12/27 Dividend
12/13/2024
Dividend Payable
12/27/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
2/04/2025

Industry, Sector and Symbol

Sector
Medical
Industry
General medical & surgical hospitals
Sub-Industry
Health Care Facilities
CUSIP
40412C10
Employees
310,000
Year Founded
1968

Price Target and Rating

Average Stock Price Target
$380.29
High Stock Price Target
$440.00
Low Stock Price Target
$271.00
Potential Upside/Downside
+16.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.74
Research Coverage
19 Analysts

Profitability

Net Income
$5.24 billion
Pretax Margin
12.55%

Debt

Sales & Book Value

Annual Sales
$64.97 billion
Cash Flow
$31.25 per share
Book Value
$3.10 per share

Miscellaneous

Free Float
249,244,000
Market Cap
$82.88 billion
Optionable
Optionable
Beta
1.68

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (NYSE:HCA) was last updated on 12/1/2024 by MarketBeat.com Staff
From Our Partners